查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598471

局部伤口护理药物市场：按产品、应用和最终用户 - 全球预测 2025-2030

Topical Wound Agents Market by Product (Cream, Gel, Spray), Application (Acute Wound, Chronic Wound), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，局部伤口护理市场价值为26.1亿美元，预计到2024年将达到28.9亿美元，复合年增长率为10.99%，预计到2030年将达到54.2亿美元。

局部伤口护理治疗是用于治疗和处理各种类型伤口的专门配方，包括擦伤、撕裂、烧烫伤和溃疡。这些范围包括促进癒合、预防感染、促进皮肤修復、解决急性和慢性伤口护理需求。对此类药物的需求源于与糖尿病相关的足部溃疡的增加、全球人口老化更容易受到意外伤害以及外科手术的普及。主要应用在医院、居家医疗和伤口诊所，产品有霜剂、软膏剂、凝胶剂等形式。最终用途的范围包括医疗保健专业人员、相关人员和患者本身，强调广泛的相关人员参与。

主要市场统计
基准年[2023] 26.1亿美元
预测年份 [2024] 28.9亿美元
预测年份 [2030] 54.2亿美元
复合年增长率（%） 10.99%

根据市场洞察，智慧敷料和生物活性伤口剂的整合等技术进步在市场成长中发挥重要作用。推动这一增长的因素包括医疗保健支出增加、对先进创伤护理意识的提高以及整容手术的增加。然而，先进的伤口护理产品也存在一些挑战，包括高成本、严格的监管核准以及不同的地区报销政策。随着医疗基础设施不断扩大和医疗需求显着未被满足，新兴市场蕴藏商机。您还可以利用数位健康解决方案进行远距伤口评估，从而融入远端医疗的趋势。对公司的建议包括策略性地关注多功能创伤护理产品的研发、促进与医疗保健提供者的合作以及优先考虑高成长地区的市场渗透策略。

创新和研究将集中于开发生物分解性、非黏性伤口敷料，并投资奈米粒子等药物传输系统，以提高创伤治疗的效率。在探索市场的本质时，值得注意的是，这是一个竞争激烈、创新主导的市场，个人化医疗仍然存在巨大的机会。能够快速适应这些动态、持续投资创新并回应患者和提供者需求的公司可能仍然能够发展并保持竞争力。

市场动态：快速发展的局部伤口护理市场的关键市场洞察

供需的动态交互作用正在改变局部伤口护理市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球急性和慢性伤口增加
    • 交通事故和伤害增加
    • 政府措施提高对伤口感染的认识
  • 市场限制因素
    • 对抗生素的担忧
  • 市场机会
    • 不断推出技术先进的产品
    • 智慧创伤护理与数位健康的出现
  • 市场挑战
    • 严格的核准流程

波特五力：开拓局部伤口护理市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解局部伤口护理药物市场的外在影响

外部宏观环境因素在塑造局部伤口护理药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解局部伤口护理药物市场的竞争状况

局部伤口护理药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵局部伤口护理市场供应商的绩效评估

FPNV定位矩阵是评估局部伤口护理市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和局部，以规划伤口护理药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对局部伤口护理药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球急性和慢性伤口的发生率增加
      • 交通事故和创伤事件增加
      • 政府加强提高对伤口感染的认识
    • 抑制因素
      • 对抗生素的担忧
    • 机会
      • 不断推出技术先进的产品
      • 智慧创伤护理与数位健康的出现
    • 任务
      • 严格的核准流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章局部伤口护理药物市场：副产品

  • 奶油
  • 凝胶
  • 喷

第七章局部伤口护理药物市场：依应用分类

  • 急性伤口
    • 烧伤
    • 外科性创伤与创伤
  • 慢性伤口
    • 糖尿病足溃疡
    • 褥疮
    • 腿部静脉性溃疡

第八章局部伤口护理药物市场：依最终使用者分类

  • 诊所
  • 医院

第九章美洲局部伤口护理市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太局部伤口护理市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的局部伤口护理市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AstraZeneca PLC
  • DUKAL LLC
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Kerecis
  • Medtronic PLC
  • Mylan NV
  • Molnlycke Health Care AB
  • Novartis International AG
  • Pfizer, Inc.
  • Smith & Nephew PLC
  • Swiss-American CDMO
  • Teva Pharmaceutical Industries Ltd
  • Themis Medicare Ltd
  • Vericel Corporation
Product Code: MRR-433C4187C5A4

The Topical Wound Agents Market was valued at USD 2.61 billion in 2023, expected to reach USD 2.89 billion in 2024, and is projected to grow at a CAGR of 10.99%, to USD 5.42 billion by 2030.

Topical wound agents are specialized formulations used for the treatment and management of various types of wounds including abrasions, lacerations, burns, and ulcers. Their scope extends to accelerating healing, preventing infections, and promoting skin regeneration, addressing both acute and chronic wound care needs. The necessity for these agents arises from rising incidences of diabetes-related foot ulcers, an aging global population vulnerable to accidental injuries, and the growing prevalence of surgical procedures. Key applications span hospital settings, home care, and specialized wound clinics, offering products in forms such as creams, ointments, and gels. End-use scope involves healthcare professionals, caregivers, and patients themselves, highlighting a broad range of stakeholder engagement.

KEY MARKET STATISTICS
Base Year [2023] USD 2.61 billion
Estimated Year [2024] USD 2.89 billion
Forecast Year [2030] USD 5.42 billion
CAGR (%) 10.99%

Market insights reveal that technological advancements, such as the integration of smart dressings and bioactive wound agents, are playing influential roles in market growth. Factors driving this growth include increasing healthcare expenditure, heightened awareness regarding advanced wound care, and a rise in cosmetic surgical procedures. However, the market faces challenges including high costs associated with advanced wound care products, stringent regulatory approvals, and variations in reimbursement policies across regions. Opportunities lie in emerging markets where healthcare infrastructure is expanding and unmet medical needs are considerable. Additionally, leveraging digital health solutions for remote wound assessment could tap into telemedicine trends. Recommendations for businesses include a strategic focus on R&D for multifunctional wound care products, fostering collaborations with healthcare providers, and prioritizing market penetration strategies in high-growth regions.

Innovation and research could pivot around developing biodegradable and non-adherent wound dressing materials or investing in enhanced drug delivery systems such as nanoparticles for greater efficiency in wound healing. While exploring the nature of the market, it is crucial to note that it remains competitive and innovation-driven, with significant opportunities still unexplored in personalized medicine. Companies well-positioned to adapt nimbly to these dynamics, continually investing in innovation and aligning with patient and provider demands, are more likely to sustain their growth and competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Topical Wound Agents Market

The Topical Wound Agents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing incidence of acute and chronic wounds globally
    • Increasing cases of road accidents and traumatic events
    • Rising government initiatives to increase awareness on wound infections
  • Market Restraints
    • Concerns pertinent to antibiotics
  • Market Opportunities
    • Ongoing introduction of technologically advanced products
    • Emergence of smart wound care and digital health
  • Market Challenges
    • Strict regulatory process for approval

Porter's Five Forces: A Strategic Tool for Navigating the Topical Wound Agents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Topical Wound Agents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Topical Wound Agents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Topical Wound Agents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Topical Wound Agents Market

A detailed market share analysis in the Topical Wound Agents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Topical Wound Agents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Topical Wound Agents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Topical Wound Agents Market

A strategic analysis of the Topical Wound Agents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Topical Wound Agents Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, DUKAL LLC, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kerecis, Medtronic PLC, Mylan N.V., Molnlycke Health Care AB, Novartis International AG, Pfizer, Inc., Smith & Nephew PLC, Swiss-American CDMO, Teva Pharmaceutical Industries Ltd, Themis Medicare Ltd, and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Topical Wound Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cream, Gel, and Spray.
  • Based on Application, market is studied across Acute Wound and Chronic Wound. The Acute Wound is further studied across Burn and Surgical & Traumatic Wound. The Chronic Wound is further studied across Diabetic Foot Ulcer, Pressure Ulcer, and Venous Leg Ulcer.
  • Based on End User, market is studied across Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of acute and chronic wounds globally
      • 5.1.1.2. Increasing cases of road accidents and traumatic events
      • 5.1.1.3. Rising government initiatives to increase awareness on wound infections
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns pertinent to antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of technologically advanced products
      • 5.1.3.2. Emergence of smart wound care and digital health
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory process for approval
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Topical Wound Agents Market, by Product

  • 6.1. Introduction
  • 6.2. Cream
  • 6.3. Gel
  • 6.4. Spray

7. Topical Wound Agents Market, by Application

  • 7.1. Introduction
  • 7.2. Acute Wound
    • 7.2.1. Burn
    • 7.2.2. Surgical & Traumatic Wound
  • 7.3. Chronic Wound
    • 7.3.1. Diabetic Foot Ulcer
    • 7.3.2. Pressure Ulcer
    • 7.3.3. Venous Leg Ulcer

8. Topical Wound Agents Market, by End User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Hospitals

9. Americas Topical Wound Agents Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Topical Wound Agents Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Topical Wound Agents Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. DUKAL LLC
  • 3. Integra LifeSciences Corporation
  • 4. Johnson & Johnson Services, Inc.
  • 5. Kerecis
  • 6. Medtronic PLC
  • 7. Mylan N.V.
  • 8. Molnlycke Health Care AB
  • 9. Novartis International AG
  • 10. Pfizer, Inc.
  • 11. Smith & Nephew PLC
  • 12. Swiss-American CDMO
  • 13. Teva Pharmaceutical Industries Ltd
  • 14. Themis Medicare Ltd
  • 15. Vericel Corporation

LIST OF FIGURES

  • FIGURE 1. TOPICAL WOUND AGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL WOUND AGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TOPICAL WOUND AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL WOUND AGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY BURN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY SURGICAL & TRAUMATIC WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY DIABETIC FOOT ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY PRESSURE ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY VENOUS LEG ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TOPICAL WOUND AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES TOPICAL WOUND AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY ACUTE WOUND, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY CHRONIC WOUND, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM TOPICAL WOUND AGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. TOPICAL WOUND AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. TOPICAL WOUND AGENTS MARKET, FPNV POSITIONING MATRIX, 2023